Laxoberal

Sodium Picosulfate, the active ingredient in Laxoberal, is a stimulant laxative presented as an oral tablet for oral use. It treats occasional constipation and is employed to cleanse the bowel before diagnostic procedures such as colonoscopy. The formulation is designed for rapid onset of action and is widely accepted in European markets.

GNH USA supplies Laxoberal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The company follows stringent quality‑assurance protocols and provides reliable logistics support for global distribution.

Sodium picosulfate is a stimulant laxative that increases intestinal motility and fluid secretion.

- Occasional constipation: promotes regular bowel movements in individuals with infrequent stools. - Colonoscopy preparation: clears the colon to allow optimal visualisation during colonoscopic examination. - Diagnostic procedure preparation: facilitates bowel cleansing before procedures such as sigmoidoscopy or radiographic studies.

Sodium picosulfate may cause a range of adverse reactions, most of which are related to its laxative activity.

Common Side Effects: - Abdominal cramps: discomfort due to increased colonic activity. - Diarrhea: loose stools resulting from accelerated transit. - Nausea: mild stomach upset in some patients. - Flatulence: excess gas production. - Urgency to defecate: sudden need to pass stool. - Mild electrolyte imbalance: transient changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Significant electrolyte disturbances: such as hypokalemia. - Rectal bleeding: uncommon but may indicate mucosal irritation. - Allergic reactions: rash, itching, or angioedema in sensitive individuals.

Before using Laxoberal, consider the following precautions.

- Assess bowel function before use: confirm the patient has not had a recent bowel movement. - Avoid use in patients with intestinal obstruction: contraindicated due to risk of perforation. - Use with caution in elderly: increased risk of dehydration and electrolyte loss. - Do not combine with other stimulant laxatives: may amplify adverse gastrointestinal effects. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Sodium picosulfate can interact with several medication classes.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the laxative efficacy. - Opioid analgesics: can counteract stimulant effects on bowel motility. - Magnesium‑containing antacids: may cause excessive electrolyte shifts.

Moderate Interactions (Monitor Closely): - Diuretics: monitor for dehydration and electrolyte imbalance. - Cardiac glycosides: watch for hypokalemia which can affect cardiac function. - Other laxatives: concurrent use increases risk of fluid loss and electrolyte disturbances.